Cannara Biotech Inc. (TSXV:LOVE)
Canada flag Canada · Delayed Price · Currency is CAD
1.310
-0.010 (-0.76%)
Apr 1, 2025, 3:28 PM EST

Cannara Biotech Ratios and Metrics

Millions CAD. Fiscal year is Sep - Aug.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Apr '25 Aug '24 Aug '23 Aug '22 Aug '21 Aug '20 2019 - 2018
Market Capitalization
120619011814970
Upgrade
Market Cap Growth
-2.56%-32.29%-23.64%-20.54%112.60%-36.02%
Upgrade
Enterprise Value
15810513114616074
Upgrade
Last Close Price
1.320.681.001.351.700.95
Upgrade
PE Ratio
17.909.5113.0251.35--
Upgrade
PS Ratio
1.360.751.583.308.7527.48
Upgrade
PB Ratio
1.310.701.131.772.321.83
Upgrade
P/TBV Ratio
0.790.701.131.772.321.84
Upgrade
P/FCF Ratio
12.1819.05----
Upgrade
P/OCF Ratio
4.525.7315.29---
Upgrade
EV/Sales Ratio
1.811.282.294.079.4029.09
Upgrade
EV/EBITDA Ratio
10.807.627.9216.9158.11-
Upgrade
EV/EBIT Ratio
18.9113.6911.1730.253041.19-
Upgrade
EV/FCF Ratio
16.1232.55----
Upgrade
Debt / Equity Ratio
0.540.550.570.730.330.34
Upgrade
Debt / EBITDA Ratio
3.343.452.755.547.15-
Upgrade
Debt / FCF Ratio
4.9915.04----
Upgrade
Asset Turnover
0.570.550.430.330.230.04
Upgrade
Inventory Turnover
1.421.411.141.401.391.09
Upgrade
Quick Ratio
0.640.730.701.751.632.32
Upgrade
Current Ratio
2.012.502.443.462.823.03
Upgrade
Return on Equity (ROE)
7.70%7.68%9.48%3.52%-2.98%-29.66%
Upgrade
Return on Assets (ROA)
3.42%3.23%5.48%2.77%0.04%-12.16%
Upgrade
Return on Capital (ROIC)
3.88%3.65%6.09%3.01%0.05%-13.06%
Upgrade
Return on Capital Employed (ROCE)
6.70%6.00%9.70%4.20%0.10%-
Upgrade
Earnings Yield
5.55%10.52%7.68%1.95%-1.03%-17.81%
Upgrade
FCF Yield
8.21%5.25%-4.39%-18.20%-22.26%-26.41%
Upgrade
Buyback Yield / Dilution
-1.10%-1.83%-2.16%-14.80%-7.26%-16.02%
Upgrade
Updated Jan 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.